JPH0832552B2 - Hydroxyapatite fine single crystal and method for producing the same - Google Patents

Hydroxyapatite fine single crystal and method for producing the same

Info

Publication number
JPH0832552B2
JPH0832552B2 JP2131064A JP13106490A JPH0832552B2 JP H0832552 B2 JPH0832552 B2 JP H0832552B2 JP 2131064 A JP2131064 A JP 2131064A JP 13106490 A JP13106490 A JP 13106490A JP H0832552 B2 JPH0832552 B2 JP H0832552B2
Authority
JP
Japan
Prior art keywords
single crystal
calcium phosphate
phosphate compound
aspect ratio
slurry
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP2131064A
Other languages
Japanese (ja)
Other versions
JPH0426509A (en
Inventor
昌弘 吉村
洪二 井奥
啓泰 竹内
健吾 岡本
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Materials Corp
Original Assignee
Mitsubishi Materials Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Materials Corp filed Critical Mitsubishi Materials Corp
Priority to JP2131064A priority Critical patent/JPH0832552B2/en
Publication of JPH0426509A publication Critical patent/JPH0426509A/en
Publication of JPH0832552B2 publication Critical patent/JPH0832552B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Description

【発明の詳細な説明】 〈産業上の利用分野〉 本発明は、ハイドロキシアパタイト微細単結晶及びそ
の製造方法に関し、更に詳しくは、カラムクロマトグラ
フィーのカラム内充填固定相剤、細胞培養・分離用担体
材料等のバイオ関連材料として有用なハイドロキシアパ
タイト微細単結晶及びその製造方法に関する。
TECHNICAL FIELD The present invention relates to a hydroxyapatite fine single crystal and a method for producing the same, more specifically, a stationary phase agent packed in a column for column chromatography, a carrier for cell culture / separation. TECHNICAL FIELD The present invention relates to a hydroxyapatite fine single crystal useful as a bio-related material such as a material and a method for producing the same.

〈従来の技術〉 従来、ハイドロキシアパタイト(以下HApと称す)結
晶粒子は、カラムクロマトグラフィーのカラム内充填固
定相剤として優れたクロマト分離能(物質分離展開能)
を有し、バイオテクノロジー分野での物質の高純度分離
精製等に不可欠な材料として応用されている。
<Prior Art> Conventionally, hydroxyapatite (hereinafter referred to as HAp) crystal particles have an excellent chromatographic separation ability (substance separation development ability) as a stationary phase agent packed in a column for column chromatography.
It is used as an essential material for high-purity separation and purification of substances in the biotechnology field.

前記HAp粒子及びその製造方法としては、特開昭62-20
2808号公報において、ブルシャイト結晶粒子の懸濁水を
脱水相転移温度から懸濁水の沸点の範囲で加熱し、脱水
相転移させて得たモネタイト懸濁水にアルカリを作用さ
せて煮沸処理することにより、出発物質であるブルシャ
イト結晶粒子の形状を保持した板状HAp結晶粒子を合成
する方法が提案されている。しかしながら、前記方法に
より得られる合成体は、いずれもHAp結晶粒子の多結晶
凝集体が得られるにすぎず、それを構成するHAp1次粒子
の形態を制御したものではないので、カラム内充填固定
相剤、細胞培養・分離用担体材料等として用いる場合
に、高精度の物質分離展開能が得られないという欠点が
ある。
The HAp particles and the method for producing the same are described in JP-A-62-20
In 2808 publication, the suspension water of the brushite crystal particles is heated in the range of the boiling point of the suspension water from the dehydration phase transition temperature, and by subjecting the monetite suspension water obtained by the dehydration phase transition to an alkali treatment and boiling treatment, A method has been proposed for synthesizing plate-like HAp crystal particles that retain the shape of the substance, brushite crystal particles. However, the synthetic body obtained by the above-mentioned method only obtains a polycrystalline aggregate of HAp crystal particles, and does not control the morphology of the HAp primary particles constituting it, so that the packed stationary phase in the column is packed. When used as an agent, a carrier material for cell culture / separation, etc., there is a drawback that a highly accurate substance separation and development ability cannot be obtained.

また特開昭61-242968号公報においては、オートクレ
ーブを用い、加圧下水硬反応を行うことにより六角柱状
HAp結晶粒子を合成する方法が提案されているが、前記
方法により合成されるHAp結晶粒子は、アスペクト比2.5
〜3.0の六角柱状1次粒子であるが、該HAp結晶粒子は、
湿式合成により得られるHAp前駆体を、800℃付近で仮焼
して得られるHAp粒子と形状的に同じにすぎず、従って
1次粒子がより精密に形状制御されたHAp結晶粒子の開
発が望まれている。
Further, in JP-A-61-242968, an autoclave is used to conduct a hydraulic reaction under pressure to produce a hexagonal columnar shape.
Although a method of synthesizing HAp crystal particles has been proposed, the HAp crystal particles synthesized by the above method have an aspect ratio of 2.5.
~ 3.0 hexagonal columnar primary particles, the HAp crystal particles are
The shape of the HAp precursor obtained by wet synthesis is the same as that of HAp particles obtained by calcination at around 800 ° C. Therefore, the development of HAp crystal particles whose primary particles are more precisely controlled in shape is desired. It is rare.

〈発明が解決しようとする課題〉 本発明の目的は、1次粒子の形状を精密に制御し、よ
り高精度の物質分離展開能等を有するHAp微細単結晶粒
子及びその製造方法を提供することにある。
<Problems to be Solved by the Invention> An object of the present invention is to provide HAp fine single crystal particles having a precisely controlled primary particle shape and having a more accurate material separation and development capability, and a method for producing the same. It is in.

〈課題を解決するための手段〉 本発明によれば、pH=10以上に調整したリン酸カルシ
ウム化合物スラリー、若しくは塩化カリウム、塩化ナト
リウム、硫酸カリウム、硫酸ナトリウムからなる添加剤
を含むリン酸カルシウム化合物スラリーを、スラリー溶
媒の沸点以上の温度において、飽和蒸気圧下、水熱処理
して得られたアスペクト比(c/a)2.0未満のハイドロキ
シアパタイト微細単結晶が提供される。
<Means for Solving the Problems> According to the present invention, a calcium phosphate compound slurry adjusted to pH = 10 or more, or a calcium phosphate compound slurry containing an additive consisting of potassium chloride, sodium chloride, potassium sulfate, and sodium sulfate, is a slurry. Provided is a hydroxyapatite fine single crystal having an aspect ratio (c / a) of less than 2.0 obtained by hydrothermal treatment under a saturated vapor pressure at a temperature equal to or higher than the boiling point of a solvent.

また本発明によれば、リン酸カルシウム化合物スラリ
ーのpHを、pH=10以上に調整したスラリー、若しくは塩
化カリウム、塩化ナトリウム、硫酸カリウム、硫酸ナト
リウムからなる添加剤を含むリン酸カルシウム化合物ス
ラリーを、スラリー溶媒の沸点以上の温度において、飽
和蒸気圧下、水熱処理することにより得られるアスペク
ト比(c/a)2.0未満のハイドロキシアパタイト微細単結
晶の製造方法が提供される。
Further, according to the present invention, the pH of the calcium phosphate compound slurry, the slurry adjusted to pH = 10 or more, or calcium phosphate compound slurry containing an additive consisting of potassium chloride, sodium chloride, potassium sulfate, sodium sulfate, the boiling point of the slurry solvent Provided is a method for producing a hydroxyapatite fine single crystal having an aspect ratio (c / a) of less than 2.0 obtained by hydrothermal treatment under saturated vapor pressure at the above temperature.

以下、本発明を更に詳細に説明する。 Hereinafter, the present invention will be described in more detail.

本発明のHAp微細単結晶は、特定方法により微細結
晶、好ましくは特定のアスペクト比を有することを特徴
とする好ましくは板状の結晶である。
The HAp fine single crystal of the present invention is a fine crystal by a specific method, preferably a plate-like crystal characterized by having a specific aspect ratio.

本発明では、例えばカラム内充填固定相剤、細胞培養
・分離用担体等として用いる場合に、細胞等の分離又は
培養能率を高めるために、微細単結晶のアスペクト比
(c/a)を2.0未満とした結晶である。アスペクト比が2.
0以上の場合には、カラム内充填固定相剤として用いる
場合、吸着率特性が低下する恐れが生ずる。
In the present invention, for example, when used as a stationary phase filling agent in a column, a carrier for cell culture / separation, etc., the aspect ratio (c / a) of the fine single crystal is less than 2.0 in order to enhance the efficiency of cell separation or culture. It is a crystal. Aspect ratio is 2.
When it is 0 or more, when used as a stationary phase agent packed in a column, the adsorption rate characteristic may be deteriorated.

また本発明のHAp微細単結晶におけるa軸及びc軸の
長さは、造粒を容易とし、カラム内充填固定相剤等に用
いる場合に、目づまり等が生じないように、a軸方向の
結晶の長さ10〜100nm、c軸方向の結晶の長さ1〜200nm
とするのが好ましい。
Further, the lengths of the a-axis and the c-axis in the HAp fine single crystal of the present invention facilitate the granulation and prevent the occurrence of clogging or the like in the a-axis direction when used as a stationary phase packing material in a column or the like. Crystal length 10 to 100 nm, crystal length in the c-axis direction 1 to 200 nm
Is preferred.

次に本発明のHAp微細単結晶を製造方法により更に詳
細に説明する。
Next, the HAp fine single crystal of the present invention will be described in more detail by the production method.

本発明のHAp微細単結晶を製造するには、まず、pH=1
0以上、好ましくはpH=12以上に調整したリン酸カルシ
ウム化合物スラリー、若しくは塩化カリウム、塩化ナト
リウム、硫酸カリウム、硫酸ナトリウムからなる添加剤
を含むリン酸カルシウム化合物スラリーを調製する。該
pH=10以上に調整したリン酸カルシウム化合物スラリー
を調製するには、例えばCa(OH)2とH3PO4とを公知の方法
により湿式合成することによりスラリーを得、次いで例
えばアンモニウア水等のpH調整剤を添加することにより
得ることができる。この際スラリー中のリン酸カルシウ
ム化合物と水との重量配合割合は、1:1〜100の範囲であ
るのが好ましい。前記リン酸カルシウム化合物スラリー
のpHが10未満の場合には、水熱領域におけるHAp微細単
結晶の形成・成長過程において、c軸の成長に必要な構
成イオンの溶解析出を抑制することができず、またc面
に水酸イオンを吸着させ、a軸の相対的な成長速度を速
めることができない。
To produce the HAp fine single crystal of the present invention, first, pH = 1
A calcium phosphate compound slurry adjusted to 0 or more, preferably pH = 12 or more, or a calcium phosphate compound slurry containing an additive consisting of potassium chloride, sodium chloride, potassium sulfate, and sodium sulfate is prepared. The
To prepare a calcium phosphate compound slurry adjusted to pH = 10 or more, for example, wet synthesizing Ca (OH) 2 and H 3 PO 4 by a known method to obtain a slurry, and then adjusting pH of ammonia water, for example. It can be obtained by adding an agent. At this time, the weight mixing ratio of the calcium phosphate compound and water in the slurry is preferably in the range of 1: 1 to 100. When the pH of the calcium phosphate compound slurry is less than 10, it is not possible to suppress dissolution and precipitation of constituent ions necessary for c-axis growth in the formation and growth process of HAp fine single crystals in the hydrothermal region. Hydroxy ions cannot be adsorbed on the c-plane, and the relative growth rate of the a-axis cannot be increased.

本発明において、微細単結晶のc面とは、六方晶系結
晶を単位格子ベクトルa,b,cによって表わした場合、a
軸とb軸とによって決められる面をc面として規定した
面である。
In the present invention, the c-plane of a fine single crystal means that when a hexagonal crystal is represented by unit cell vectors a, b, c,
The surface defined by the axis and the b axis is defined as the c surface.

一方、これとは別に、塩化カリウム、塩化ナトリウ
ム、硫酸カリウム、硫酸ナトリウムからなる添加剤を加
え、アスペクト比(c/a)が20未満の微細結晶を得るこ
ともできる。該添加剤を含むリン酸カルシウム化合物ス
ラリーを調製するには、前記リン酸カルシウム化合物の
調製時、調製後又は調製時と調製後の両方に添加剤を加
えることにより得ることができる。該添加剤は、HAp微
細単結晶のc面に陰イオンを吸着させるか又はc軸方向
で結晶を溶解させるもの若しくはa軸の成長速度を速め
ることが可能であるか又はこれらの効果を有するもので
あって、具体的には例えば、塩化カリウム、塩化ナトリ
ウム、硫酸カリウム、硫酸ナトリウムである。この際添
加剤の添加量は、リン酸カルシウム化合物スラリー100
重量部に対して0.1〜50重量部の範囲であるのが好まし
い。
On the other hand, apart from this, it is also possible to obtain fine crystals having an aspect ratio (c / a) of less than 20 by adding an additive consisting of potassium chloride, sodium chloride, potassium sulfate and sodium sulfate. The calcium phosphate compound slurry containing the additive can be prepared by adding the additive during preparation of the calcium phosphate compound, after preparation, or both during preparation and after preparation. The additive is capable of adsorbing anions on the c-plane of the HAp fine single crystal, dissolving the crystal in the c-axis direction, or capable of accelerating the growth rate of the a-axis, or having these effects. Specifically, for example, potassium chloride, sodium chloride, potassium sulfate, and sodium sulfate. In this case, the additive amount of the calcium phosphate compound slurry 100
It is preferably in the range of 0.1 to 50 parts by weight with respect to parts by weight.

HAp微細単結晶を製造するには、次いで前記pH=10以
上に調整したリン酸カルシウム化合物スラリー、若しく
は塩化カリウム、塩化ナトリウム、硫酸カリウム、硫酸
ナトリウムからなる添加剤を含むリン酸カルシウム化合
物スラリーを、スラリー溶媒の沸点以上の温度におい
て、好ましくは100〜300℃において、飽和蒸気圧下、好
ましくは0.1〜20MPa下、水熱処理することにより得るこ
とができる。該水熱処理は公知のオートクレーブ等を用
いて、前記条件下行えば良く、更に好ましくは水熱処理
を0.1〜24時間行うことによって、所望のアスペクト比
を有するHAp微細単結晶を得ることができる。該水熱処
理における反応温度がスラリー溶媒の沸点温度未満の場
合には、反応が進行せず、また圧力が飽和蒸気圧未満の
場合には、結晶性が向上しない。
In order to produce HAp fine single crystals, the calcium phosphate compound slurry adjusted to pH = 10 or above or the calcium phosphate compound slurry containing an additive consisting of potassium chloride, sodium chloride, potassium sulfate and sodium sulfate is added to the boiling point of the slurry solvent. It can be obtained by hydrothermal treatment at the above temperature, preferably 100 to 300 ° C., under saturated vapor pressure, preferably 0.1 to 20 MPa. The hydrothermal treatment may be carried out under the conditions described above using a known autoclave, and more preferably the hydrothermal treatment is carried out for 0.1 to 24 hours, whereby a HAp fine single crystal having a desired aspect ratio can be obtained. When the reaction temperature in the hydrothermal treatment is lower than the boiling temperature of the slurry solvent, the reaction does not proceed, and when the pressure is lower than the saturated vapor pressure, the crystallinity is not improved.

本発明のHAp微細単結晶は、必要に応じ公知の方法に
より精製処理して使用することができる。
The HAp fine single crystal of the present invention can be used after purification treatment if necessary by a known method.

〈発明の効果〉 本発明のHAp微細単結晶は、特定方法により製造さ
れ、アスペクト比(c/a)が2.0未満であり、しかもカル
シウムサイトが表面により多く存在する微細単結晶のc
面を選択的に成長させ、相対的に多く露出させているた
め、カルシウムサイトに親和性を有する生化学物質、細
胞等の分離又は培養能率を選択的に高めることができ、
従って、カラム内充填固定相剤、細胞培養・分離用担体
材料等に極めて有用である。また本発明の製造方法で
は、特定の条件下、単に水熱処理することによりHAp微
細単結晶を得ることができるので、工業的にも極めて有
用である。
<Effects of the Invention> The HAp fine single crystal of the present invention is produced by a specific method, has an aspect ratio (c / a) of less than 2.0, and has a large amount of calcium sites on the surface.
Since the surface is selectively grown and relatively exposed to a large amount, it is possible to selectively increase the efficiency of separation or culture of biochemical substances having affinity for calcium sites, cells, etc.
Therefore, it is extremely useful as a stationary phase agent packed in a column, a carrier material for cell culture / separation, and the like. Further, according to the production method of the present invention, a HAp fine single crystal can be obtained by simply subjecting it to hydrothermal treatment under specific conditions, which is extremely useful industrially.

〈実施例〉 以下本発明を実施例及び比較例により更に詳細に説明
するが、本発明はこれらに限定されるものではない。
<Examples> The present invention will be described in more detail with reference to Examples and Comparative Examples, but the present invention is not limited thereto.

実施例1 Ca(OH)2と85重量%H3PO4とを湿式合成して、リン酸カ
ルシウム化合物10重量%スラリーを得た。得られたリン
酸カルシウム化合物スラリー500mlに、pH調整剤として
アンモニア水を添加溶解し、pH=10,12に調整した。次
いで得られた各スラリーをオートクレーブに充填し、20
0℃,2MPa,5時間の条件で水熱処理した。処理終了後、得
られた各スラリーを蒸留水1を用いて洗浄し、濾過し
た後、乾燥器にて100℃にて乾燥した。得られたハイド
ロキシアパタイト微細結晶の形状をX線回折法により解
析したところ、結晶子径がpH=10ではa軸方向の結晶の
長さ80nm、c軸方向の結晶の長さ50nm、アスペクト比
(c/a)=1.6、pH=12ではa軸方向の長さ50nm、c軸方
向の長さ50nm、アスペクト比(c/a)が1.0の板状単結晶
であった。
Example 1 Ca (OH) 2 and 85 wt% H 3 PO 4 were wet-synthesized to obtain a 10 wt% slurry of calcium phosphate compound. Ammonia water as a pH adjuster was added and dissolved in 500 ml of the obtained calcium phosphate compound slurry to adjust the pH to 10,12. Then, each of the obtained slurries was charged into an autoclave, and
Hydrothermal treatment was performed under the conditions of 0 ℃, 2MPa and 5 hours. After the treatment was completed, each of the obtained slurries was washed with distilled water 1, filtered, and then dried at 100 ° C. in a drier. The shape of the obtained hydroxyapatite fine crystals was analyzed by X-ray diffraction. When the crystallite size was pH = 10, the crystal length in the a-axis direction was 80 nm, the crystal length in the c-axis direction was 50 nm, and the aspect ratio ( When c / a) = 1.6 and pH = 12, the plate-shaped single crystal had a length in the a-axis direction of 50 nm, a length in the c-axis direction of 50 nm, and an aspect ratio (c / a) of 1.0.

実施例2 pH調整剤アンモニア水の代わりに、添加剤KClを5g添
加混合した以外は、実施例1と同様にして結晶子径が、
a軸方向の結晶の長さ45nm,c軸方向の結晶の長さ80nm,
アスペクト比(c/a)が1.8の板状のHAp単結晶が得られ
た。
Example 2 The crystallite diameter was the same as in Example 1 except that 5 g of the additive KCl was added and mixed instead of the pH adjuster ammonia water.
The crystal length in the a-axis direction is 45 nm, the crystal length in the c-axis direction is 80 nm,
Plate-like HAp single crystals with an aspect ratio (c / a) of 1.8 were obtained.

比較例1 リン酸カルシウム化合物スラリーにpH調整剤又は添加
剤を加えない以外は、実施例1と同様にして結晶子径
が、a軸方向の結晶の長さ50nm,c軸方向の結晶の長さ14
0nm,アスペクト比(c/a)が2.8の六角柱状のHAp単結晶
を得た。
Comparative Example 1 The crystallite size was 50 nm in the a-axis direction and the crystal length in the c-axis direction was 14 nm in the same manner as in Example 1 except that the pH adjusting agent or the additive was not added to the calcium phosphate compound slurry.
Hexagonal HAp single crystal with 0 nm and aspect ratio (c / a) of 2.8 was obtained.

試験例 実施例1(pH=12のスラリーを用いて得た微細結
晶),2及び比較例1で得られたHAp微細結晶乾燥物を、
それぞれ粉砕・分級し、144nm以下の凝集粉体とした。
得られた粉体にバインダーとして、商品名「マクセロ
ン」(信越化学株式会社製)を粉体に対して5重量%添
加混合し、金型で加圧成形した後、粉砕・分級し、粒径
0.3〜0.5mmの顆粒を得た。更に得られた顆粒を電気炉に
て、900℃、3時間、昇降温速度5℃/分にて焼成し、
細胞培養用カラム充填材をそれぞれ25g得た。この充填
材を容量で各3mlカラムに詰め、マウス頭蓋冠由来骨原
料細胞MC3T3-E1の細胞懸濁液(105〜106個程度)1mlを
カラムに投入した。次いでカラムを密閉系にし、展開溶
媒として商品名「α−MEM(ヘーゼルトン社製)を用
い、ポンプで培地を5ml/分の溶出速度で流した。カラム
から溶出させた培地10mlを小試験管に回収し、血球計算
板(萱垣製作所製)によってカウントされた溶出細胞数
から吸着率を算出した。その結果を表−1に示す。表−
1の結果から細胞培養用カラム充填材としての吸着率特
性は、アスペクト比(c/a)に反比例して、すなわちa
面又はb面の有効面積に比例して増大することがわかっ
た。
Test Example The dried HAp fine crystal product obtained in Example 1 (fine crystals obtained by using a slurry of pH = 12), 2 and Comparative Example 1 was
Each was pulverized and classified to obtain an aggregate powder of 144 nm or less.
As a binder, 5% by weight of the product powder, "Maxellon" (manufactured by Shin-Etsu Chemical Co., Ltd.), was added and mixed as a binder to the obtained powder, and the mixture was pressure-molded with a die, crushed and classified, and the particle size
Granules of 0.3-0.5 mm were obtained. Further, the obtained granules are fired in an electric furnace at 900 ° C. for 3 hours at a temperature rising / falling rate of 5 ° C./minute,
25 g of each cell culture column packing material was obtained. This packing material was packed in a volume of 3 ml in each column, and 1 ml of a cell suspension (about 10 5 to 10 6 cells) of mouse calvaria-derived bone material cells MC3T3-E1 was loaded into the column. Next, the column was closed, and the medium "α-MEM (manufactured by Hazelton)" was used as the developing solvent, and the medium was caused to flow by a pump at an elution rate of 5 ml / min. 10 ml of the medium eluted from the column was added to a small test tube. The adsorption rate was calculated from the number of eluted cells counted by a hemocytometer (Kayagaki Seisakusho), and the results are shown in Table 1.
From the result of 1, the adsorption rate characteristic as a cell culture column packing material is inversely proportional to the aspect ratio (c / a), that is, a
It was found to increase in proportion to the effective area of the plane or b plane.

フロントページの続き (72)発明者 岡本 健吾 埼玉県秩父郡横瀬町大字横瀬2270番地 三 菱鉱業セメント株式会社セラミックス研究 所内 (56)参考文献 特開 昭53−111000(JP,A) 特開 昭61−151010(JP,A)Front page continuation (72) Inventor Kengo Okamoto 2270 Yokoze, Yokoze-cho, Chichibu-gun, Saitama Sanryo Mining & Cement Co., Ltd. Ceramics Research Laboratory (56) Reference JP-A-53-111000 (JP, A) JP-A-61 -151010 (JP, A)

Claims (4)

【特許請求の範囲】[Claims] 【請求項1】pH=10以上に調整したリン酸カルシウム化
合物スラリーを、スラリー溶媒の沸点以上の温度におい
て、飽和常気圧下、水熱処理して得られるアスペクト比
(c/a)2.0未満のハイドロキシアパタイト微細単結晶。
1. A hydroxyapatite fine powder having an aspect ratio (c / a) of less than 2.0 obtained by subjecting a calcium phosphate compound slurry adjusted to pH = 10 or more to a hydrothermal treatment at a temperature not lower than the boiling point of a slurry solvent under saturated normal pressure. Single crystal.
【請求項2】塩化カリウム、塩化ナトリウム、硫酸カリ
ウム、硫酸ナトリウムからなる添加剤を含むリン酸カル
シウム化合物スラリーを、スラリー溶媒の沸点以上の温
度において、飽和蒸気圧下、水熱処理して得られるアス
ペクト比(c/a)2.0未満のハイドロキシアパタイト微細
単結晶。
2. An aspect ratio (c) obtained by subjecting a calcium phosphate compound slurry containing an additive consisting of potassium chloride, sodium chloride, potassium sulfate and sodium sulfate to a hydrothermal treatment under a saturated vapor pressure at a temperature not lower than the boiling point of the slurry solvent. / a) Hydroxyapatite fine single crystal of less than 2.0.
【請求項3】リン酸カルシウム化合物スラリーのpHを、
pH=10以上に調整し、スラリー溶媒の沸点以上の温度に
おいて、飽和常気圧下、水熱処理して得られるアスペク
ト比(c/a)2.0未満のハイドロキシアパタイト微細単結
晶。
3. The pH of the calcium phosphate compound slurry,
A hydroxyapatite fine single crystal having an aspect ratio (c / a) of less than 2.0, which is obtained by performing a hydrothermal treatment under a saturated atmospheric pressure at a temperature of not less than 10 and a boiling point of a slurry solvent or higher.
【請求項4】塩化カリウム、塩化ナトリウム、硫酸カリ
ウム、硫酸ナトリウムからなる添加剤を含むリン酸カル
シウム化合物スラリーを、スラリー溶媒の沸点以上の温
度において、飽和蒸気圧下、水熱処理して得られるアス
ペクト比(c/a)2.0未満のハイドロキシアパタイト微細
単結晶の製造方法。
4. An aspect ratio (c) obtained by subjecting a calcium phosphate compound slurry containing an additive consisting of potassium chloride, sodium chloride, potassium sulfate, and sodium sulfate to a hydrothermal treatment under a saturated vapor pressure at a temperature not lower than the boiling point of the slurry solvent. / a) A method for producing a hydroxyapatite fine single crystal of less than 2.0.
JP2131064A 1990-05-21 1990-05-21 Hydroxyapatite fine single crystal and method for producing the same Expired - Lifetime JPH0832552B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2131064A JPH0832552B2 (en) 1990-05-21 1990-05-21 Hydroxyapatite fine single crystal and method for producing the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2131064A JPH0832552B2 (en) 1990-05-21 1990-05-21 Hydroxyapatite fine single crystal and method for producing the same

Publications (2)

Publication Number Publication Date
JPH0426509A JPH0426509A (en) 1992-01-29
JPH0832552B2 true JPH0832552B2 (en) 1996-03-29

Family

ID=15049164

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2131064A Expired - Lifetime JPH0832552B2 (en) 1990-05-21 1990-05-21 Hydroxyapatite fine single crystal and method for producing the same

Country Status (1)

Country Link
JP (1) JPH0832552B2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0798650B2 (en) * 1993-01-11 1995-10-25 工業技術院長 Method for producing plate-shaped hydroxyapatite
KR100787526B1 (en) * 2006-12-29 2007-12-21 순천향대학교 산학협력단 Synthesis of spherical shaped hydroxyapatite, alpha-tricalcium phosphate and beta-tricalcium phosphate nano powders depending on the ph by microwave assisted process
JP2009298666A (en) * 2008-06-16 2009-12-24 Okayama Prefecture Hydroxyapatite
JP6230362B2 (en) * 2013-10-08 2017-11-15 HOYA Technosurgical株式会社 Powder manufacturing method
CN109133022A (en) * 2018-09-12 2019-01-04 河南大学 A kind of hydroxyapatite nano-structure of morphology controllable, preparation method and application

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5951485B2 (en) * 1977-03-11 1984-12-14 東京医科歯科大学長 Production method of CaO-P↓2O↓5-based apatite
JPS61151010A (en) * 1984-12-25 1986-07-09 Central Glass Co Ltd Production of hydroxy apatite

Also Published As

Publication number Publication date
JPH0426509A (en) 1992-01-29

Similar Documents

Publication Publication Date Title
AU595237B2 (en) Calcium-phosphate type hydroxyapatite and process for producing same
US4781904A (en) Calcium-phosphate type hydroxyapatite for chromatographic separation and process for producing same
US5427754A (en) Method for production of platelike hydroxyapatite
JP2001526169A (en) Method for producing magnesium and carbonate substituted hydroxyapatite
US10843166B2 (en) Adsorbent particles
WO2003042098A1 (en) Granular zirconium phosphate and methods for synthesis of same
JPH0832552B2 (en) Hydroxyapatite fine single crystal and method for producing the same
TWI615360B (en) Adsorbent particles and granulating adsorbent
JP6731934B2 (en) Adsorbent dispersion and adsorption method
JP2507920B2 (en) Method for producing acid-resistant filter aid using calcium silicate
JP2004330113A (en) Production method of adsorbent and adsorbent
JPH0784323B2 (en) Hydroxyapatite fine crystals and method for producing the same
JP2756703B2 (en) Spherical apatite, method for producing the same, and molded article with porous structure
JP3163360B1 (en) High concentration synthesis of tubular aluminum silicate by continuous addition of precursor
US5217699A (en) Calcium-phosphate type hydroxyapatite
JPH0788206B2 (en) Method for producing hydroxyapatite fine particle aggregate
JPH0665635B2 (en) Molding material
JP3066498B1 (en) Method for producing spherical polymer beads coated with hydroxyapatite
JPS61122121A (en) Production of rare earth metal oxide powder
JP7133748B1 (en) Adsorbents and adsorption devices
JP3352757B2 (en) Packing material for liquid chromatography
RU2165389C1 (en) Method of preparing finely dispersed single-phase hydroxyl apatite
US20120238444A1 (en) Powder, method of producing powder and adsorption apparatus
JP2902274B2 (en) Separation and purification of chromatographic stationary phase materials and biologically relevant polymer samples
SU1193145A1 (en) Method of producing fine pulverulent mullite power